You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. Read More The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
52 Week High
52 Week Low
Eli Lilly to put Loxo executives in charge of new cancer research unit(Reuters) - U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo Oncology
Global Attention Deficit Hyperactivity Disorder Market Spotlight 2019 Featuring Allergan, Eli Lilly, Johnson & Johnson, Takeda, Teva - ResearchAndMarkets.comThe "Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)?" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight repo
Available Jan 30, Pre-Market